Dexmedetomidine and Meperidine Additively Reduce the Shivering Threshold in Humans

Author:

Doufas Anthony G.1,Lin Chun-Ming1,Suleman Mohammad-Irfan1,Liem Edwin B.1,Lenhardt Rainer1,Morioka Nobutada1,Akça Ozan1,Shah Yunus M.1,Bjorksten Andrew R.1,Sessler Daniel I.1

Affiliation:

1. From the Outcomes Research Institute and the Department of Anesthesiology (A.G.D., C.-M.L., M.-I.S., E.B.L., R.L., N.M., O.A., Y.M.S., D.I.S.), Louisville, Ky; the Department of Anesthesiology (C.-M.L.), Chang Gung Memorial Hospital, Taipei, Taiwan; the Department of Anesthesia, Tokyo Women’s Medical College (N.M.), Tokyo, Japan; the Department of Anaesthesia (A.R.B.), Royal Melbourne Hospital, Parkville, Australia; and the Ludwig Boltzmann Institute (D.I.S.), University of Vienna, Vienna, Austria.

Abstract

Background and Purpose— Hypothermia might prove to be therapeutically beneficial in stroke victims; however, even mild hypothermia provokes vigorous shivering. Meperidine and dexmedetomidine each linearly reduce the shivering threshold (triggering core temperature) with minimal sedation. We tested the hypothesis that meperidine and dexmedetomidine synergistically reduce the shivering threshold without producing substantial sedation or respiratory depression. Methods— We studied 10 healthy male volunteers (18 to 40 years) on 4 days: (1) control (no drug); (2) meperidine (target plasma level 0.3 μg/mL); (3) dexmedetomidine (target plasma level 0.4 ng/mL); and (4) meperidine plus dexmedetomidine (target plasma levels of 0.3 μg/mL and 0.4 ng/mL, respectively). Lactated Ringer’s solution (≈4°C) was infused through a central venous catheter to decrease tympanic membrane temperature by ≈2.5°C/h; mean skin temperature was maintained at 31°C. An increase in oxygen consumption >25% of baseline identified the shivering threshold. Sedation was evaluated by using the Observer’s Assessment of Sedation/Alertness scale. Two-way repeated-measures ANOVA was used to identify interactions between drugs. Data are presented as mean±SD; P <0.05 was statistically significant. Results— The shivering thresholds on the study days were as follows: control, 36.7±0.3°C; dexmedetomidine, 36.0±0.5°C ( P <0.001 from control); meperidine, 35.5±0.6°C ( P <0.001); and meperidine plus dexmedetomidine, 34.7±0.6°C ( P <0.001). Although meperidine and dexmedetomidine each reduced the shivering threshold, their interaction was not synergistic but additive ( P =0.19). There was trivial sedation with either drug alone or in combination. Respiratory rate and end-tidal P co 2 were well preserved on all days. Conclusions— Dexmedetomidine and meperidine additively reduce the shivering threshold; in the small doses tested, the combination produced only mild sedation and no respiratory toxicity.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Advanced and Specialised Nursing,Cardiology and Cardiovascular Medicine,Clinical Neurology

Cited by 139 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3